Our Mission

The mission of the Pediatric Early Phase Clinical Trials Network (PEP-CTN) is to identify and develop effective new agents and treatment strategies for children and adolescents with cancer, through rational and efficient clinical and laboratory research. PEP-CTN clinical trials will incorporate correlative genomics, biology, pharmacology, imaging studies and patient reported outcomes to further the understanding of the disposition and action of new agents introduced into the treatment of children with cancer.